A Safety and Tolerability Study of Pemigatinib in Japanese Subjects With Advanced Malignancies - (FIGHT-102)
Clinical trial NCT03235570 · COMPLETED
Trial details
- NCT number
- NCT03235570
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-01
- Primary completion
- 2020-03-04
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.